JP2019517576A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019517576A5 JP2019517576A5 JP2019514190A JP2019514190A JP2019517576A5 JP 2019517576 A5 JP2019517576 A5 JP 2019517576A5 JP 2019514190 A JP2019514190 A JP 2019514190A JP 2019514190 A JP2019514190 A JP 2019514190A JP 2019517576 A5 JP2019517576 A5 JP 2019517576A5
- Authority
- JP
- Japan
- Prior art keywords
- excipient
- beta
- mixed
- liquid formulation
- hydroxyisovaleric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002775 capsule Substances 0.000 claims 3
- RWBRUCCWZPSBFC-UHFFFAOYSA-N 17-(1-hydroxyethyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one Chemical compound C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(O)C)C1(C)CC2 RWBRUCCWZPSBFC-UHFFFAOYSA-N 0.000 claims 2
- AXFYFNCPONWUHW-UHFFFAOYSA-N beta-hydroxy-beta-methyl butyric acid Natural products CC(C)(O)CC(O)=O AXFYFNCPONWUHW-UHFFFAOYSA-N 0.000 claims 2
- 239000012669 liquid formulation Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662341464P | 2016-05-25 | 2016-05-25 | |
| US62/341,464 | 2016-05-25 | ||
| PCT/US2017/034551 WO2017205673A1 (en) | 2016-05-25 | 2017-05-25 | Stabilization of beta-hydroxyisovaleric acid formulations in soft gel capsules |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019517576A JP2019517576A (ja) | 2019-06-24 |
| JP2019517576A5 true JP2019517576A5 (enExample) | 2020-06-11 |
| JP6929939B2 JP6929939B2 (ja) | 2021-09-01 |
Family
ID=60411620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019514190A Active JP6929939B2 (ja) | 2016-05-25 | 2017-05-25 | ソフトゲルカプセルにおけるベータ−ヒドロキシイソ吉草酸製剤の安定化 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US10959957B2 (enExample) |
| EP (1) | EP3463327B1 (enExample) |
| JP (1) | JP6929939B2 (enExample) |
| KR (1) | KR102384266B1 (enExample) |
| CN (2) | CN121177244A (enExample) |
| AU (1) | AU2017270219B2 (enExample) |
| CA (1) | CA3024584A1 (enExample) |
| CO (1) | CO2018014085A2 (enExample) |
| MX (1) | MX2018014407A (enExample) |
| MY (1) | MY199597A (enExample) |
| RU (1) | RU2018145520A (enExample) |
| WO (1) | WO2017205673A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111888325A (zh) * | 2020-08-04 | 2020-11-06 | 瑞希(重庆)生物科技有限公司 | 一种卡拉胶凝胶、药物赋形剂和皮肤外用制剂 |
| JP7750505B2 (ja) * | 2021-10-14 | 2025-10-07 | 中日本カプセル 株式会社 | カプセル及びカプセルの製造方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2870062A (en) * | 1956-04-27 | 1959-01-20 | Scherer Corp R P | Gelatin composition for capsules |
| US5200191A (en) | 1991-09-11 | 1993-04-06 | Banner Gelatin Products Corp. | Softgel manufacturing process |
| US5569466A (en) | 1995-05-17 | 1996-10-29 | R. P. Scherer Corporation | Fill compositions for soft elastic gel capsules |
| US6340473B1 (en) * | 1999-07-07 | 2002-01-22 | R.P. Scherer Technologies, Inc. | Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| DE10064312C2 (de) | 2000-12-22 | 2003-05-22 | Degussa | Cholinpyruvat-Hydrat, Verfahren zu dessen Herstellung, Cholinpyruvat-Hydrat enthaltende Formulierung sowie deren Verwendung |
| US7740878B2 (en) * | 2001-10-22 | 2010-06-22 | Danisco A/S | Use of betaine to enhance exercise performance |
| ES2294197T3 (es) | 2001-12-21 | 2008-04-01 | Supernus Pharmaceuticals, Inc. | Formulacion de capsula oral con estabilidad fisica aumentada. |
| DE10208568A1 (de) | 2002-02-27 | 2003-09-18 | Degussa Bioactives Deutschland | Verbindung, enthaltend Kreatin, eine Säure-Komponente und/oder einen Komplex-Bildner |
| DE10217557A1 (de) | 2002-04-19 | 2003-11-06 | Degussa Bioactives Gmbh | Funktionsnahrungsmittel enthaltend eine Phospholipid-haltige stabile Matrix |
| US20050215640A1 (en) | 2004-03-26 | 2005-09-29 | Baxter Jeffrey H | HMB compositions and uses thereof |
| US8231896B2 (en) * | 2004-11-08 | 2012-07-31 | R.P. Scherer Technologies, Llc | Non-gelatin soft capsule system |
| DE102004060914A1 (de) | 2004-12-17 | 2006-07-06 | Bioghurt Biogarde Gmbh & Co. Kg | Verwendung von Liponsäure-haltigen Cyclodextrin-Komplexen |
| EP2242489A1 (en) * | 2005-02-15 | 2010-10-27 | Jallal Messadek | Combination therapeutic compositions and method of use |
| DE102005061765A1 (de) | 2005-05-19 | 2006-11-23 | Degussa FreshTech Beverages LLC, Milwaukee | Füllmaterial für einen Getränkebehälter |
| CN101574146B (zh) * | 2008-05-07 | 2012-06-13 | 北京康比特体育科技股份有限公司 | 一种含有hmb的运动营养补剂 |
| JP2009153529A (ja) | 2009-04-17 | 2009-07-16 | Tsujido Chemical Corp | 食品組成物 |
| ES2608483T3 (es) * | 2009-12-18 | 2017-04-11 | Metabolic Technologies, Inc. | Método mejorado de administración de beta-hidroxi-beta-metilbutirato (HMB) |
| MX2013007347A (es) | 2010-12-22 | 2013-08-01 | Abbott Lab | Productos nutricionales que comprenden beta-hidroxi-beta metilbutirato de calcio y acido linoleico conjugado. |
| RU2631597C2 (ru) * | 2011-07-15 | 2017-09-25 | Нусерт Сайенсиз, Инк. | Композиции и способы модулирования метаболических путей |
| EP3733171B1 (en) * | 2012-09-10 | 2023-10-25 | Metabolic Technologies, LLC | Compositions comprising hmb and atp as well as their use |
| AU2013344753B2 (en) | 2012-11-13 | 2018-09-27 | Nusirt Sciences, Inc. | Compositions and methods for increasing energy metabolism |
| US20140272000A1 (en) | 2013-03-14 | 2014-09-18 | Metabolic Technologies, Inc. | Liquids and Foodstuffs Containing beta-hydroxy-beta-methylbutyrate (HMB) in the Free Acid Form and Methods of Manufacturing or Producing the Same |
| WO2014152098A1 (en) * | 2013-03-15 | 2014-09-25 | Banner Pharmacaps Inc. | Non-gelatin enteric soft capsules |
| JP2016520050A (ja) | 2013-05-01 | 2016-07-11 | アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ | 老化筋肉再生の増強方法 |
| EP3082778B1 (en) * | 2013-12-18 | 2019-04-03 | Capsugel Belgium NV | Stable liquid filled hard capsule comprising beta-hydroxy-beta-methylbutyric acid |
| US20150366813A1 (en) * | 2014-06-20 | 2015-12-24 | Banner Life Sciences Llc | Liquid-filled immediate release soft gelatin capsules |
| JP2018090504A (ja) * | 2016-11-30 | 2018-06-14 | 株式会社東洋新薬 | 筋肉増強用組成物 |
-
2017
- 2017-05-25 MX MX2018014407A patent/MX2018014407A/es unknown
- 2017-05-25 MY MYPI2018002008A patent/MY199597A/en unknown
- 2017-05-25 CN CN202511046150.0A patent/CN121177244A/zh active Pending
- 2017-05-25 EP EP17803618.2A patent/EP3463327B1/en active Active
- 2017-05-25 JP JP2019514190A patent/JP6929939B2/ja active Active
- 2017-05-25 AU AU2017270219A patent/AU2017270219B2/en active Active
- 2017-05-25 CN CN201780031975.2A patent/CN109562087A/zh active Pending
- 2017-05-25 CA CA3024584A patent/CA3024584A1/en active Pending
- 2017-05-25 RU RU2018145520A patent/RU2018145520A/ru not_active Application Discontinuation
- 2017-05-25 WO PCT/US2017/034551 patent/WO2017205673A1/en not_active Ceased
- 2017-05-25 KR KR1020187037387A patent/KR102384266B1/ko active Active
- 2017-05-25 US US15/605,664 patent/US10959957B2/en active Active
-
2018
- 2018-12-24 CO CONC2018/0014085A patent/CO2018014085A2/es unknown
-
2021
- 2021-03-30 US US17/217,913 patent/US12133920B2/en active Active
-
2024
- 2024-11-04 US US18/936,798 patent/US20250057773A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Riehl et al. | The 2-category theory of quasi-categories | |
| Parker | Conditioned flavor avoidance and conditioned gaping: rat models of conditioned nausea | |
| ES2549694A1 (es) | Procedimiento de llenado aséptico de una bolsa | |
| CO2017002472A2 (es) | Formulación de acetato de abiraterona | |
| HK1247856A1 (zh) | 羟丙基β-环糊精组合物及方法 | |
| WO2012174379A3 (en) | Polyhedral cage-containing metalloporphyrin frameworks, methods of making, and methods of using | |
| HK1220445A1 (zh) | 具有摇溶性以及增强的溶解再现性和稳定性的组合物 | |
| Mironov et al. | Racah matrices and hidden integrability in evolution of knots | |
| WO2018084627A3 (en) | Pharmaceutical complex formulation comprising amlodipine, losartan and chlorthalidone | |
| HK1216839A1 (zh) | 调整释放制剂 | |
| EP4279137A3 (en) | Oral pharmaceutical composition and method for producing particulate formulation comprising composition | |
| AU2015244572A1 (en) | Multipurpose medical image indicator and method for manufacturing same | |
| JP2019517576A5 (enExample) | ||
| WO2016009400A3 (en) | An improved thermostable spray dried rotavirus vaccine formulation and process thereof | |
| IL286068A (en) | A drug mixing device, a drug mixing kit including the same and a method for its production | |
| Suzuki et al. | Formulas for the Walsh coefficients of smooth functions and their application to bounds on the Walsh coefficients | |
| WO2016130786A3 (en) | Flaviviridae proteins and virions and methods of use thereof | |
| WO2016133333A3 (en) | An oral pharmaceutical formulation comprising sustained-release granules containing tamsulosin hydrochloride | |
| JP2015113322A5 (enExample) | ||
| MY175693A (en) | A method to produce slow release delivery carrier lipid nanoparticles of different log p value | |
| MY181972A (en) | Drug composition and soft capsule drug sealing the drug composition | |
| BR112017003135A2 (pt) | partículas de gelatina/pectina | |
| Aluja et al. | Correction to: Development of the Zuckerman–Kuhlman–Aluja Personality Questionnaire (ZKA–PQ): A Factor/Facet Version of the Zuckerman–Kuhlman Personality Questionnaire (ZKPQ) | |
| YOSHIOKA et al. | Practice and Evaluation of'Nurse Call Art'Workshops as Active Art Consideration of Design Elements of the Program and Works | |
| Nomura et al. | 224Ra/228Ra Ratios in coastal lagoon and the water dynamics in Lake Shinjiko |